Current understanding of verbal fluency in Alzheimer's disease: evidence to date

LM Wright, M De Marco, A Venneri - Psychology Research and …, 2023 - Taylor & Francis
Since their development, verbal fluency tests (VFTs) have been used extensively throughout
research and in clinical settings to assess a variety of cognitive functions in diverse …

Targeting the function of the transentorhinal cortex to identify early cognitive markers of Alzheimer's disease

C Bastin, E Delhaye - Cognitive, Affective, & Behavioral Neuroscience, 2023 - Springer
Initial neuropathology of early Alzheimer's disease accumulates in the transentorhinal
cortex. We review empirical data suggesting that tasks assessing cognitive functions …

Semantic memory as an early cognitive marker of Alzheimer's disease: Role of category and phonological verbal fluency tasks

C Marra, C Piccininni… - Journal of …, 2021 - journals.sagepub.com
Background: The assessment of semantic memory may be a useful marker to identify
individuals with mild cognitive impairment (MCI) who will progress to Alzheimer's disease …

[HTML][HTML] Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia

GM Giuffrè, D Quaranta, EM Costantini, S Citro… - Neurobiology of …, 2023 - Elsevier
Introduction CSF Neurofilament light chain (NfL) is a promising biomarker of
neurodegeneration, but its utility in discriminating between Alzheimer's disease (AD) and …

Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes

SM Bell, H Wareing, F Capriglia, R Hughes… - Molecular …, 2024 - nature.com
Abnormalities in cellular metabolism are seen early in Alzheimer's disease (AD). Astrocyte
support for neuronal function has a high metabolic demand, and astrocyte glucose …

Verbal fluency discrepancies as a marker of the prehippocampal stages of Alzheimer's disease.

LM Wright, M De Marco, A Venneri - Neuropsychology, 2023 - psycnet.apa.org
Objective: Prior to evidence of episodic memory decline, a lengthy preclinical phase of
Alzheimer's disease (AD) exists characterized by the build-up of tau pathology within …

A graph theory approach to clarifying aging and disease related changes in cognitive networks

LM Wright, M De Marco, A Venneri - Frontiers in aging neuroscience, 2021 - frontiersin.org
In accordance with the physiological networks that underlie it, human cognition is
characterized by both the segregation and interdependence of a number of cognitive …

Sensitivity of the preclinical Alzheimer's cognitive composite (PACC), PACC5, and repeatable battery for neuropsychological status (RBANS) to amyloid status in …

KV Papp, H Rofael, AE Veroff, MC Donohue… - The Journal of …, 2022 - Springer
Background Cognitive composites commonly serve as primary outcomes in Alzheimer's
disease (AD) secondary prevention trials. Objective To evaluate the association between …

Neural and behavioral correlates of episodic memory are associated with temporal discounting in older adults

KM Lempert, DJ Mechanic-Hamilton, L **e, LEM Wisse… - Neuropsychologia, 2020 - Elsevier
When facing decisions involving trade-offs between smaller, sooner and larger, delayed
rewards, people tend to discount the value of future rewards. There are substantial …

Semantic processing and neurobiology in Alzheimer's disease and mild cognitive impairment

VN Almeida, M Radanovic - Neuropsychologia, 2022 - Elsevier
In the present theoretical review we will perform a critical surveillance of linguistic and
semantic processing in Mild Cognitive Impairment and Alzheimer's disease, explicitly …